SDC1 and myeloid sarcoma: On the other hand, the number of plasma cells (identified as CD138+ cells) and the plasma cell/B cell ratio were higher in active lesions from progressive MS patients (Figure 2), suggesting that infiltrating B cells could gradually differentiate into plasma cells during the disease course.